MX2021005481A - Metodos para aislar y expandir celulas. - Google Patents

Metodos para aislar y expandir celulas.

Info

Publication number
MX2021005481A
MX2021005481A MX2021005481A MX2021005481A MX2021005481A MX 2021005481 A MX2021005481 A MX 2021005481A MX 2021005481 A MX2021005481 A MX 2021005481A MX 2021005481 A MX2021005481 A MX 2021005481A MX 2021005481 A MX2021005481 A MX 2021005481A
Authority
MX
Mexico
Prior art keywords
methods
interleukin
isolating
tissue sample
expanding cells
Prior art date
Application number
MX2021005481A
Other languages
English (en)
Inventor
Mark Uden
Oliver Nussbaumer
Shristi Bhandari
Samuel Florence
Andrew Hutton
Louisa Mathias
Kalle Soderstrom
Original Assignee
Gammadelta Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gammadelta Therapeutics Ltd filed Critical Gammadelta Therapeutics Ltd
Publication of MX2021005481A publication Critical patent/MX2021005481A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0638—Cytotoxic T lymphocytes [CTL] or lymphokine activated killer cells [LAK]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/24—Gas permeable parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2304—Interleukin-4 (IL-4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2309—Interleukin-9 (IL-9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2315—Interleukin-15 (IL-15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2321—Interleukin-21 (IL-21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención se refiere a un método para el aislamiento de linfocitos (en particular células T ?d) de una muestra de tejido no hematopoyético que comprende los pasos de: cultivar una muestra de tejido no hematopoyético en la presencia de (a) interleucina-2 (IL-2) o 5 interleucina-9 (IL-9); (b) interleucina-15 (IL-15) y (c) interleucina-21 (IL-21); y recolectar una población de linfocitos cultivados de la muestra de tejido no hematopoyético; se proporcionan métodos de expansión posterior, así como poblaciones de células aisladas obtenidas por el método y usos del mismo.
MX2021005481A 2018-11-08 2019-11-08 Metodos para aislar y expandir celulas. MX2021005481A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18205287 2018-11-08
PCT/GB2019/053164 WO2020095058A1 (en) 2018-11-08 2019-11-08 Methods for isolating and expanding cells

Publications (1)

Publication Number Publication Date
MX2021005481A true MX2021005481A (es) 2021-11-04

Family

ID=64270643

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005481A MX2021005481A (es) 2018-11-08 2019-11-08 Metodos para aislar y expandir celulas.

Country Status (13)

Country Link
US (1) US20220010277A1 (es)
EP (1) EP3877509A1 (es)
JP (1) JP2022506836A (es)
KR (1) KR20210111746A (es)
CN (1) CN113423820A (es)
AU (1) AU2019374488A1 (es)
BR (1) BR112021008461A2 (es)
CA (1) CA3117895A1 (es)
EA (1) EA202190871A1 (es)
IL (1) IL282876A (es)
MX (1) MX2021005481A (es)
PH (1) PH12021551037A1 (es)
WO (1) WO2020095058A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY197176A (en) 2018-02-01 2023-05-30 Nkmax Co Ltd Method of producing natural killer cells and composition for treating cancer
GB202105113D0 (en) 2021-04-09 2021-05-26 Gammadelta Therapeutics Ltd Novel method
TW202328434A (zh) 2021-08-03 2023-07-16 英商伽馬三角洲療法有限公司 γδＴ細胞之工程改造及其組成物
WO2023194915A1 (en) 2022-04-04 2023-10-12 Gammadelta Therapeutics Ltd Novel gene armoring
GB202204926D0 (en) 2022-04-04 2022-05-18 Gammadelta Therapeutics Ltd Method for expanding gammadelta T cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
JP4435985B2 (ja) * 1998-11-04 2010-03-24 ヘモソル インコーポレーテッド ＴｃＲγδＴ細胞の生産方法
CN103173354B (zh) 2003-10-08 2017-07-14 威尔森沃尔夫制造公司 利用透气性材料进行细胞培养的方法及装置
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
EP1963369B1 (en) 2005-11-28 2013-05-15 Zymogenetics, Inc. Il-21 antagonists
EP3211001B1 (en) 2010-12-22 2020-10-07 The Board of Trustees of the Leland Stanford Junior University Superagonists and antagonists of interleukin-2
ES2643387T3 (es) * 2011-05-19 2017-11-22 Instituto De Medicina Molecular Estirpe celular de linfocitos que comprende células gama-delta, composición y método de producción de la misma
UA123821C2 (uk) * 2014-06-11 2021-06-09 Полібіосепт Гмбх Композиція для експансії лімфоцитів in vitro
BR112018008293A2 (pt) 2015-10-30 2018-10-30 Cancer Research Tech Ltd expansão de células t gama delta não hematopoiéticas residentes no tecido e o uso dessas células
JOP20190224A1 (ar) * 2017-03-29 2019-09-26 Iovance Biotherapeutics Inc عمليات من أجل إنتاج الخلايا اللمفاوية المرتشحة للأورام واستخداماتها في العلاج المناعي
GB201707048D0 (en) 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
WO2018229163A1 (en) * 2017-06-14 2018-12-20 King's College London Methods of activating v delta 2 negative gamma delta t cells

Also Published As

Publication number Publication date
CN113423820A (zh) 2021-09-21
EP3877509A1 (en) 2021-09-15
IL282876A (en) 2021-06-30
PH12021551037A1 (en) 2022-01-03
CA3117895A1 (en) 2020-05-14
US20220010277A1 (en) 2022-01-13
EA202190871A1 (ru) 2021-09-15
WO2020095058A1 (en) 2020-05-14
BR112021008461A2 (pt) 2021-08-03
JP2022506836A (ja) 2022-01-17
AU2019374488A1 (en) 2021-05-27
KR20210111746A (ko) 2021-09-13

Similar Documents

Publication Publication Date Title
PH12021551037A1 (en) Methods for isolating and expanding cells
PH12021551038A1 (en) Methods for isolating and expanding cells
MX2016016251A (es) Expansion de linfocitos con composicion de citocinas para inmunoterapia celular activa.
MY198084A (en) Expansion of non-haematopoietic tissue-resident ()()t cells and uses of these cells
MY177268A (en) Medium system and method for ex vivo expansion of nk cells
WO2018097540A3 (ko) 무혈청면역세포배양용 배지첨가키트, 상기 키트를 이용한 면역세포배양방법, 상기 키트 또는 배양방법에 의해 얻어진 무혈청면역세포배양액 및 상기 배양액을 포함하는 화장료조성물
MY161389A (en) Method for amplifying nk cells
MY187629A (en) System and method for cell levitation and monitoring
WO2007146334A3 (en) Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
MX2022010521A (es) Metodo para producir linfocitos citoliticos naturales a partir de celulas madre pluripotentes.
BR112018004454A2 (pt) nova subpopulação de tregs cd8+cd45rcbaixo e seu uso
MX2021005021A (es) Proceso para producir celulas t geneticamente modificadas.
ATE511751T1 (de) Verfahren für die produktion von milben
EP1904624A4 (en) METHOD FOR THE CULTIVATION AND REPRODUCTION OF HEMATOPOETIC STEM CELLS AND PRECURSOR CELLS USING HUMAN ENDOMETRIUM CELLS
EP4306169A3 (en) Means and methods for generation of breast stem cells
MX2021012556A (es) Sistema y metodo de extraccion y criopreservacion de medula osea.
SG11201903254PA (en) Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells
WO2014152524A3 (en) Novel method of protein purification
NZ708061A (en) Methods for generating genetically superior animals
EP3967753A4 (en) PROCESS FOR CULTIVATION OF ALLOGOUS IMMUNITY CELLS, IMMUNITY CELL CULTURE OBTAINED THEREBY AND IMMUNITY CELL THERAPEUTIC THEREFORE
PL439808A1 (pl) Sposoby i kompozycje hodowli komórkowych do produkcji przeciwciał
EP4248991A3 (en) Methods and materials for expanding antigen-specific t cells in culture
WO2018155952A3 (ko) 인간 뇌 조직 유래 신경줄기세포의 고효율 분리 방법
MX2022002091A (es) Metodos para determinar la idoneidad del tejido de timo cultivado para la implantacion en humanos y metodos de uso asociados.
EP3778872A4 (en) CELL CULTURE METHOD, METHOD FOR PRODUCING A CELL-SUPPORT COMPLEX, CULTIVATED CELL AND CELL-SUPPORT COMPLEX